Viking Therapeutics (NASDAQ:VKTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.

Open	$64.64
Close	$61.93
Volume / Avg.	3.72M / 3.89M
Day Range	$61.59 - $64.83
52 Wk Range	8.28 - 99.41
Market Cap	$6.90B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	20.82%
Days to Cover	4.53

Recent News

US Stocks Stall, Gold Updates Record Highs, Tesla Rallies: What's Driving Markets Monday?

Wall Street kicked off the week on a cautious note, with major indexes trading relatively flat as investors seek more clarity on the economic and political landscape.

Piero Cingari

Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan

JPMorgan analyst Hardik Parikh initiated coverage on Viking Therapeutics with an Overweight rating and a December 2025 price target of $80.

Surbhi Jain

Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected.

Michael Juliano

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$64.64
Close	$61.93
Volume / Avg.	3.72M / 3.89M
Day Range	$61.59 - $64.83
52 Wk Range	8.28 - 99.41
Market Cap	$6.90B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	50
Short Interest	20.82%
Days to Cover	4.53

About Viking Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of bio...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Viking Therapeutics (VKTX) stock?

You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.

View our list of the best stock brokerages

Who are Viking Therapeutics (VKTX) competitors?

Other companies in Viking Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), Exact Sciences (NASDAQ:EXAS) and Sarepta Therapeutics (NASDAQ:SRPT).

What is the forecast, or price target, for Viking Therapeutics (VKTX) stock?

Viking Therapeutics has a consensus price target of $79.87.

What is the current price for Viking Therapeutics (VKTX)?

The stock price for Viking Therapeutics (NASDAQ: VKTX) is $62.24 last updated September 24, 2024 at 7:59 PM EDT.

Does Viking Therapeutics (VKTX) pay a dividend?

There are no upcoming dividends for Viking Therapeutics.

When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?

Viking Therapeutics’s Q3 earnings are confirmed for Wednesday, October 23, 2024.

Is Viking Therapeutics (VKTX) going to split?

There is no upcoming split for Viking Therapeutics.

What sector and industry does Viking Therapeutics (VKTX) operate in?

Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge